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HYPOTHESIS
A multivalent cholera toxin chimera containing the Staphylococcus aureus antigens 'map' , 'aaa', and 'cvFC' will provide protection against S. aureus mastitis.

BACKGROUND

RESULTS

S. aureus is the primary cause of mastitis in cows. Mastitis is
an infection of the mammary gland in the udder, which can be
devastating for the animal and milk production. It is the most
economically significant disease in the dairy industry. Creating
a vaccine for S. aureus in dairy animals could reduce the
number of antibiotics administered and prevent millions in
economic losses annually1. Cholera toxin can be used as an
effective vaccine by replacing its toxic subunit with S. aureus
antigens. The goal of this research is to create a vaccine that
will induce antigen-specific immune responses that prevent the
establishment of infection and mastitis development.

INTRODUCTION
Cholera toxin (CT) is composed
of the toxic catalytic A subunit
(CTA) and nontoxic binding B
subunit (CTB)

1. Cloning aaa, map, and cvFC
A/B/C. Design for protein chimera including CTB and either
MHC class II analog protein (map), autolysin aaa, or conserved
virulence factor C (cvFC) from S. aureus
2. Transformation
A/B/C. Agarose gel of colony PCR confirmed cloning and
transformation into E. coli cells was successful
3. Expression and Purification

1A. Plasmid map of pAJW001 including
S.aureus antigen 'map'

2A. 528 bp band present of 'map' from colony
PCR on clones

3A. SDS-PAGE gel of purified pAJW001 protein

A/B. SDS-PAGE gel shows
only CTB subunit is present after
protein expression and
purification of pAJW001 and
pAJW002
Next Step

Toxic A subunit may be
replaced by a protein from S.
aureus to create a specified
immune response in a nontoxic vaccine

Design protein chimera with a
polypeptide linker to adhere
subunits together as seen in the
plasmid map of pAJW003.
Linkers can aid in the structure,
folding, stability, and activity of
fusion proteins3

Chimera refers to the fusion of
the antigen tag and B subunit
CT naturally enhances immune
response, allowing for mucosal
delivery. No more needles!

DISCUSSION

CONCLUSION

The figure above displays the natural
structure of the cholera toxin protein
complex.2

METHODS

Three S. aureus antigens were cloned into a vector
containing the B subunit of cholera toxin

1B. Plasmid map of pAJW002 including S.
aureus antigen 'aaa'

2B. 404 bp band present of 'aaa' from colony
PCR on clones

3B. SDS-PAGE gel of purified pAJW002 protein
from two colonies

2C. 855 bp band present of 'cvFC' from colony
PCR on clones

ACKNOWLEDGEMENTS
Supported by an Institutional Development Award (IDeA) from the National
Institute of General Medical Sciences of the National Institutes of Health
under Grant #P20GM103408

The purification of the protein chimeras analyzed through
an SDS-PAGE gel shows an absence of the antigen
subunit
Future direction includes
redesigning the protein stucture
and creating a new clone
The new chimera will include a
flexible polypeptide linker to join the
protein subunits and promote
proper folding for purification

The figure above shows a
simplified graphic of a linker4
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